These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 28573462

  • 41. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.
    Petersen E, Nielsen HV, Christiansen L, Spenter J.
    Vaccine; 1998 Aug; 16(13):1283-9. PubMed ID: 9682392
    [Abstract] [Full Text] [Related]

  • 42. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M, Zhao L, Song J, Li Y, Zhao Q, He S, Cong H.
    Vaccine; 2013 Sep 23; 31(41):4536-40. PubMed ID: 23933373
    [Abstract] [Full Text] [Related]

  • 43. DNA vaccination with a gene encoding Toxoplasma gondii Rhoptry Protein 17 induces partial protective immunity against lethal challenge in mice.
    Wang HL, Wang YJ, Pei YJ, Bai JZ, Yin LT, Guo R, Yin GR.
    Parasite; 2016 Sep 23; 23():4. PubMed ID: 26842927
    [Abstract] [Full Text] [Related]

  • 44. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
    Peng GH, Yuan ZG, Zhou DH, He XH, Liu MM, Yan C, Yin CC, He Y, Lin RQ, Zhu XQ.
    Vaccine; 2009 Nov 05; 27(47):6570-4. PubMed ID: 19720368
    [Abstract] [Full Text] [Related]

  • 45. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
    Liu Y, Cao A, Li Y, Li X, Cong H, He S, Zhou H.
    BMC Infect Dis; 2017 Jun 07; 17(1):403. PubMed ID: 28592247
    [Abstract] [Full Text] [Related]

  • 46. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D, Wang S, Cai W, Du A.
    Vaccine; 2008 Aug 18; 26(35):4541-8. PubMed ID: 18590785
    [Abstract] [Full Text] [Related]

  • 47. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice.
    Li XZ, Lv L, Zhang X, Anchang KY, Abdullahi AY, Tu L, Wang X, Xia L, Zhang XX, Feng W, Lu C, Li S, Yuan ZG.
    Infect Genet Evol; 2016 Nov 18; 45():447-453. PubMed ID: 27742446
    [Abstract] [Full Text] [Related]

  • 48. Evaluation on the immune response induced by DNA vaccine encoding MIC8 co-immunized with IL-12 genetic adjuvant against Toxoplasma gondii infection.
    Zhao HG, Huang FY, Guo JL, Tan GH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Aug 18; 31(4):284-9. PubMed ID: 24812879
    [Abstract] [Full Text] [Related]

  • 49. Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of Toxoplasma gondii.
    Zheng L, Hu Y, Hua Q, Luo F, Xie G, Li X, Lin J, Wan Y, Ren S, Pan C, Tan F.
    Acta Trop; 2017 Feb 18; 166():336-342. PubMed ID: 27940233
    [Abstract] [Full Text] [Related]

  • 50. Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis.
    Wang HL, Li YQ, Yin LT, Meng XL, Guo M, Zhang JH, Liu HL, Liu JJ, Yin GR.
    PLoS One; 2013 Feb 18; 8(8):e70884. PubMed ID: 23967128
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
    Nie H, Fang R, Xiong BQ, Wang LX, Hu M, Zhou YQ, Zhao JL.
    Vet Parasitol; 2011 Sep 27; 181(2-4):215-21. PubMed ID: 21632181
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Studies on the immuno-protection of ROP2 nuclei acid vaccine in Toxoplasma gondii infection].
    Wei QK, Li J, Fu TX, Bai XL, Cui Y, Zhang DB, Wang HF, Liu YB, Fu B, Zai DF, Huang BC, Liu KY, Han GD.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct 27; 24(5):337-41. PubMed ID: 17361811
    [Abstract] [Full Text] [Related]

  • 55. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
    Cuppari AF, Sanchez V, Ledesma B, Frank FM, Goldman A, Angel SO, Martin V.
    Vaccine; 2008 Sep 15; 26(39):5040-5. PubMed ID: 18675873
    [Abstract] [Full Text] [Related]

  • 56. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D, Staats HF, Gonçalves T, Borges O.
    Eur J Pharm Biopharm; 2015 Jun 15; 93():149-64. PubMed ID: 25818119
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Partial protective immunity against toxoplasmosis in mice elicited by recombinant Toxoplasma gondii malate dehydrogenase.
    Liu Z, Yuan F, Yang Y, Yin L, Liu Y, Wang Y, Zheng K, Cao J.
    Vaccine; 2016 Feb 10; 34(7):989-94. PubMed ID: 26514423
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5.
    Zhang NZ, Huang SY, Xu Y, Chen J, Wang JL, Tian WP, Zhu XQ.
    Clin Vaccine Immunol; 2014 Jul 10; 21(7):924-9. PubMed ID: 24789795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.